Publications by authors named "Isabel Grau"

Claim this Profile
C
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study.
Ana López González, Sonia Del Barco Berrón, Isabel Grau, Maria Galan, Beatriz Castelo Fernández

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis